Tag: Prostaglandin inhibitors

In the United States, over 70 million prescriptions for NSAIDs—a primary class of prostaglandin inhibitors—are written each year [1.4.2]. Understanding **what happens if prostaglandins are inhibited** is key to grasping both the therapeutic benefits and the significant physiological risks involved.

In clinical trials, prostaglandin inhibitors effectively alleviate pain in approximately 70-80% of individuals suffering from conditions like dysmenorrhea. This success stems from understanding **how do prostaglandin inhibitors work** at a molecular level to block specific inflammatory processes.